Venn Life Sciences Share Discussion Threads

[rivaldo] 05/10/2015 08:38

Cheers Tech - can you give any details of the narrative?

Small buying having a nice effect now.

[tech] 03/10/2015 11:47

Very good update in Techinvest and added another 40K to portfolio

[yump] 28/9/2015 14:49

A bit o/t but interesting? was reading recently about the start of the collection of monitoring data from hospital operations (which will include drug data).

Currently its all deleted after 48-96 hours, but the contention is that a load of useful data is going missing, particularly in the light of any subsequent changes in health (good or bad) in patients, where there is currently no way of looking back over their history during an operation.

Sounds like a proper big data application, so keeping a lookout for any companies coming to market that might get involved. Pretty early days yet though.

[yorgi] 25/9/2015 11:04

The video interview with CEO outlines clearly the business plan for the latest acquisition and form all I could see from their latest results they are a well run company steadily building a sound business which could soon become profitable.

This is in an industry where there should be plenty of opportunities to win further contracts and continue to build the company.

I thought the drop was unwarranted in light of what was revealed this week.

[yump] 24/9/2015 16:21

He does seem sound on face value yes.

I think the career path is:

30 second news
regional weather girl
GMTV
BBC Breakfast
Strictly
TV Quiz shows and then steadily downhill to:
Advert voiceovers...

[paleje] 24/9/2015 16:17

She always smiles like that, Yump, hoping to get spotted for a bit part in the movies or maybe weather girl on one of the regionals. She doesn't ask tough questions but then none of them do, if they did no one would go on. Richardson seems coolly competent though.

[proactivest] 23/9/2015 12:43

Video interview with CEO Richardson



Tony Richardson, chief executive Venn Life Sciences (LON:VENN), says the company’s acquisition of Dutch drug consultancy Kinesis allows it to pair early and late-stage drug development together.

Venn currently offers clinical trial management, monitoring and biometric data services to customers in the later phases of developing treatments.

But Kinesis will allow it to supply more early-stage technical services, such as working out how a drug should be administered or how quickly it has worked its way through the body.

[proactivest] 23/9/2015 12:04

Video interview with CEO Richardson



Tony Richardson, chief executive Venn Life Sciences (LON:VENN), says the company’s acquisition of Dutch drug consultancy Kinesis allows it to pair early and late-stage drug development together.

Venn currently offers clinical trial management, monitoring and biometric data services to customers in the later phases of developing treatments.

But Kinesis will allow it to supply more early-stage technical services, such as working out how a drug should be administered or how quickly it has worked its way through the body.

[eburne1960] 22/9/2015 15:58

Already on the website:

hxxp://www.vennlifesciences.com/wp-content/uploads/2015/05/237915-Venn-Life-Sciences-Circular-web.pdf

Replace "hxxp" with "http"

[mr hangman] 22/9/2015 15:19

When are the doc's for the 22p placing being issued for all shareholders ?

[mulligut] 22/9/2015 15:09

Stig I suspect that the CEO did not lie. Without full disclosure to all shareholders in a RNS it would be a criminal offense to inform one shareholder over another. So it is likely, not having seen the interview, that a question asked went unanswered to avoid such a material event being made public.

As you rightly pointed out a discernible investor would put two and two together from events leading up to any announcement and suspect that one might well be imminent.

Yump, if you are buying a company just to boost revenues then they would have over paid. However, from my own business experience, I suspect that with 120 staff and acquiring more there is scope for savings in administrational overhead as well as cross selling into new markets from both VENN and the acquired company. The sum of the parts should well exceed the individual parts. Also buying on historical EBITDA does not reflect future EBITDA and in the case of what I read they are paying 40% mostly in earn outs for targets being met in deferred cash and shares. The targets reflect a higher return and ultimately it is expected that should they be reached then the price paid would be fair value and likely to be a much lower P/E.

Again only opinion so wise to do your own research

[yump] 22/9/2015 14:54

mulligut

Quite. Placings for acquisitions haven't done IDEA any harm.

Success depends on the business model - imo the trick is figuring that out, as there are plenty of placings to support AIM stocks that are not growing revenues much, or as you say unprofitable businesses (where quite often the model is simply not working).

Only issue is getting a grip on the figures post acquisition.

If my estimate is right they've paid about 10x ebitda.

[the stigologist] 22/9/2015 14:33

Yes anyone with half a brain knows that. So why do people get so defensive about it and deny that a placing is needed ? Why do CEOs lie in interviews when asked the question ?

[mulligut] 22/9/2015 14:26

Sometimes I wonder if some people are more concerned about a placing of shares than what the placing of the shares are for. In this case it is to use the market for what it was intended to be used for, i.e., an acquisition for growth. There are many valuable uses for broadening the shareholder base. It makes for greater liquidity, underwrites the value of the growth strategy, especially when such a placing is over subscribed, as in this case, and it bolsters the working capital chest for both integration of the acquired business and driving the growth of a profitable company.

So for my money I think the results and the acquisition are positioning the company for an accelerated growth beyond profitability that no longer needs VCT and EIS as a crutch to sustain an unprofitable company. In this case the business is growing so it will always find future investors who believe in management and the business model and are happy to invest and share in future ROI.

Good luck to all, and management of VENN

[rivaldo] 22/9/2015 13:46

Brief analyst comment amongst other coverage:

http ://www.proactiveinvestors.co.uk/companies/news/110995/venn-life-sciences-to-offer-one-stop-shop-service-with-kinesis-pharma-deal-110995.html

"William Lynne at broker Hybridan said Venn was a good match with Kinesis.

He added that half-yearly results were well on track to meet market expectations, with €9m in new contract wins.

"Combined with the accretive contribution from Kinesis, the future looks very promising," he said."

[shorttozero] 22/9/2015 11:01

Yes always best to stick your head in the sand and not listen to both sides of the argument.

[yorgi] 22/9/2015 10:57

I started looking at these last week and all I read looked very interesting in both the short term and especially for the longer term. The results are good as expected and the acquisition will only add to what appears to be a well run company with a good business plan.

I'm very pleased to have bought in and the small placing to fund the acquisition does not concern me as it is to grow the business.

I would just filter stig, I have for a long time and as you can all see he spends hours and hours day after day trolling stocks. Definitely not worth reading let alone replying.

[mr hangman] 22/9/2015 10:27

Sometimes the best bit of tech, is just the simple filter button

[the stigologist] 22/9/2015 10:23

The CEO actually danced around the Placing issue in this Interview.

www.proactiveinvestors.co.uk/LON:VENN/Venn-Life-Sciences-Holdings/

Although it was pretty obvious to anybody who can read the signs.

June a puff article on Proactive.
July a puff interview on Proactive.
September announce a Placing.

[mr hangman] 22/9/2015 10:09

There is always one...

[the stigologist] 22/9/2015 10:07

Apparently according to a credible poster on these threads the CEO outright LIED by saying the Company did not require funding and would not place at the current levels !!!

This is when he had PAID to go on a shill site which accepts money to promote your company to retail punters so OBVIOUSLY knew that he would ramp the stock prior to a Placing

Do you think this acquisition turned up out of the blue ?

Why if they ONLY needed to raise money for the Acquisition are they RAISING MORE CASH than the actual cash component of the deal ?

Your credibility and integrity is zero here so best you just keep quiet.

[the stigologist] 22/9/2015 10:03

rivaldo you are either blind or a lying scumbag

I did not edit my post at all. Don't try to deflect away from your own stupidity by trying to cast aspersions on others thanks.